Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.985
+0.025 (1.28%)
Jul 22, 2025, 1:37 PM - Market open
Ernexa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 1.92 | 1.73 | 7.58 | 11.45 | 16.99 | 1.63 | Upgrade |
Cash & Short-Term Investments | 1.92 | 1.73 | 7.58 | 11.45 | 16.99 | 1.63 | Upgrade |
Cash Growth | -62.51% | -77.18% | -33.82% | -32.61% | 942.02% | -67.50% | Upgrade |
Other Receivables | 0.16 | 0.44 | 0.43 | 0.95 | 0.68 | - | Upgrade |
Receivables | 0.16 | 0.44 | 0.43 | 0.95 | 0.68 | - | Upgrade |
Prepaid Expenses | 0.14 | 0.19 | 1.6 | 1.28 | 1.1 | 0.1 | Upgrade |
Total Current Assets | 2.21 | 2.35 | 9.6 | 13.68 | 18.77 | 1.73 | Upgrade |
Property, Plant & Equipment | 0.69 | 0.76 | 33.27 | 1.27 | 3.24 | 2.69 | Upgrade |
Long-Term Investments | - | - | - | 0.06 | 1 | - | Upgrade |
Goodwill | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade |
Long-Term Deferred Charges | - | - | - | - | 5.99 | 5.99 | Upgrade |
Other Long-Term Assets | 0.12 | 0.12 | 4.22 | 5.23 | 0.49 | 0.45 | Upgrade |
Total Assets | 5.06 | 5.27 | 49.13 | 22.28 | 31.53 | 12.91 | Upgrade |
Accounts Payable | 1.28 | 1.72 | 1.07 | 1.62 | 1.76 | 1.28 | Upgrade |
Accrued Expenses | 1.35 | 1.01 | 2.88 | 4.1 | 1.01 | 1.05 | Upgrade |
Short-Term Debt | 2.25 | - | - | - | - | 0.41 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.12 | Upgrade |
Current Portion of Leases | 0.21 | 0.21 | 2.22 | 0.3 | 0.43 | 0.27 | Upgrade |
Current Income Taxes Payable | 0.01 | 0 | 0 | - | - | - | Upgrade |
Current Unearned Revenue | - | - | 0.19 | - | - | - | Upgrade |
Other Current Liabilities | 5.34 | - | 0.22 | 1.64 | 0.49 | - | Upgrade |
Total Current Liabilities | 10.44 | 2.94 | 6.57 | 7.65 | 3.68 | 3.13 | Upgrade |
Long-Term Debt | - | - | 6.77 | - | - | 0.19 | Upgrade |
Long-Term Leases | 0.42 | 0.48 | 32.85 | 0.89 | 2.3 | 1.91 | Upgrade |
Long-Term Unearned Revenue | - | - | 0.39 | - | - | - | Upgrade |
Other Long-Term Liabilities | 0.15 | 0.15 | 0.31 | 1.63 | 0.05 | 0.02 | Upgrade |
Total Liabilities | 11.01 | 3.57 | 46.9 | 10.17 | 6.02 | 5.25 | Upgrade |
Common Stock | 0.26 | 0.26 | 0.03 | 0.03 | 0.01 | 25.8 | Upgrade |
Additional Paid-In Capital | 233.53 | 232.98 | 189.19 | 177.38 | 166.19 | - | Upgrade |
Retained Earnings | -239.74 | -231.54 | -186.98 | -165.3 | -140.7 | -18.14 | Upgrade |
Total Common Equity | -5.95 | 1.7 | 2.23 | 12.11 | 25.5 | 7.66 | Upgrade |
Shareholders' Equity | -5.95 | 1.7 | 2.23 | 12.11 | 25.5 | 7.66 | Upgrade |
Total Liabilities & Equity | 5.06 | 5.27 | 49.13 | 22.28 | 31.53 | 12.91 | Upgrade |
Total Debt | 2.88 | 0.68 | 41.84 | 1.18 | 2.72 | 2.9 | Upgrade |
Net Cash (Debt) | -0.96 | 1.05 | -34.27 | 10.26 | 14.26 | -1.27 | Upgrade |
Net Cash Growth | - | - | - | -28.03% | - | - | Upgrade |
Net Cash Per Share | -0.56 | 1.15 | -96.73 | 50.46 | 98.81 | -21.63 | Upgrade |
Filing Date Shares Outstanding | 4.16 | 3.48 | 0.36 | 0.34 | 0.19 | 0.06 | Upgrade |
Total Common Shares Outstanding | 3.48 | 3.43 | 0.36 | 0.34 | 0.17 | 0.06 | Upgrade |
Working Capital | -8.23 | -0.59 | 3.03 | 6.03 | 15.09 | -1.39 | Upgrade |
Book Value Per Share | -1.71 | 0.50 | 6.19 | 35.42 | 147.07 | 130.26 | Upgrade |
Tangible Book Value | -8 | -0.34 | 0.19 | 10.06 | 23.46 | 5.62 | Upgrade |
Tangible Book Value Per Share | -2.30 | -0.10 | 0.52 | 29.44 | 135.28 | 95.50 | Upgrade |
Machinery | - | 0.26 | 0.33 | 0.27 | 0.41 | 0.3 | Upgrade |
Leasehold Improvements | - | - | 0.27 | - | 0.46 | 0.41 | Upgrade |
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.